ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 753218 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 753218; 2) Community: the network communities that were significantly associated with the response to NSC 753218; 3) Molecule: the relationships between components within communities and NSC 753218; 4) MDR: the compounds that were significantly associated with the NSC 753218.

NSC Compound Enrichment Correlation
NSC 709925 Null 0.0123744972338279 -0.14107048
NSC 717838 Null 0.0123744972338279 -0.16140102
NSC 720326 2-(5,6,7-Trimethoxyindol-2-carbonyl)amino-4H-pyrazolo[1,5-a] indole 0.0123744972338279 -0.037532161
NSC 732517 Dasatinib 0.0123744972338279 -0.13337005
NSC 733164 Null 0.0123744972338279 0.22667684
NSC 744020 methyl 1-(4-[(11aR)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxybutyl)-2-(1-methyl-1H-3-indolyl)-1H-benzo[d]imidazole-6-carboxylate 0.0123744972338279 0.0099652387
NSC 95466 PCNU 0.0133299224082802 0.35369301
NSC 104801 Cytembena 0.0133299224082803 0.23959084
NSC 107043 Null 0.0133299224082803 0.39367661
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0133299224082803 0.18243151
Total:82  Current:31    [First] [Prev] [Next] [Last]